N
ENZ

Nuveen’s Enzo Biochem, Inc. ENZ Stock Holding History

Nuveen’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-215,319
Closed -$741K – 3559
2021
Q1 		$741K Sell
215,319
-18,910
-8% -$58.8K ﹤0.01% 2996
2020
Q4 		$590K Sell
234,229
-5,125
-2% -$11.2K ﹤0.01% 2997
2020
Q3 		$505K Sell
239,354
-48,228
-17% -$115K ﹤0.01% 2953
2020
Q2 		$644K Buy
287,582
+119,095
+71% +$306K ﹤0.01% 2801
2020
Q1 		$426K Sell
168,487
-49,922
-23% -$123K ﹤0.01% 2825
2019
Q4 		$574K Sell
218,409
-142,810
-40% -$427K ﹤0.01% 2876
2019
Q3 		$1.3M Buy
361,219
+143,553
+66% +$508K ﹤0.01% 2581
2019
Q2 		$733K Buy
+217,666
New +$767K ﹤0.01% 2869

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen's ENZ Position: Q2 2021 in Review

Nuveen sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 215,319 shares — an estimated $741K sold.

Nuveen first reported a position in ENZ in Q2 2019 and held it in 8 quarters. The position peaked at $1.3M in Q3 2019. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

  • Nuveen reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 215,319 Enzo Biochem, Inc. shares in Q2 2021, an estimated $741K.
  • Nuveen first reported a position in Enzo Biochem, Inc. in Q2 2019 and held it in 8 quarters.
  • Nuveen's Enzo Biochem, Inc. position peaked at $1.3M in Q3 2019.
  • 72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.